FindTrial
Sign In

Research for lncRNAs and miRNAs uesd in glioma as clinical diagnosis biomarkers

Research for lncRNAs and miRNAs uesd in glioma as clinical diagnosis biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13003373
Enrollment
Unknown
Registered
2013-07-17
Start date
2013-08-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Gold Standard:
Index test:

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Serum samples from patients who were diagnosed with glioma according to The People's Republic of China health departmentd diagnostic criteria of glioma(version 2011); 2. In-hospital patients from neurosurgery of Nanfang Hospital; 3. subjects are aged 18-80, Gender Not Required; 4. written informed consent was obtained from all subjects.

Exclusion criteria

Exclusion criteria: 1. Inability to comply with study-related procedures; 2. patient not suitable for Neurosurgery; 3. any other cilical trials within 30 days pre-vaccination; 4. Female patients who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
lncRNA;—

Contacts

Public ContactQian Wang
wangqian@fimmu.com+86 020-61641007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026